Advanced search
Publication Cover
Acta Oncologica Volume 56, 2017 - Issue 7
Journal homepage
1,550
Views
11
CrossRef citations to date
0
Altmetric
ORIGINAL ARTICLES: PROSTATE CANCER

Stage-specific mortality and survival trends of prostate cancer patients in Finland before and after introduction of PSA

Heikki A. SeikkulaDepartment of Surgery, Central Hospital of Central Ostrobothnia, Kokkola, Finland; ;Department of Urology, Turku University Hospital, University of Turku, Turku, Finland; Correspondence[email protected]
,
Antti J. KaipiaSatakunta Hospital District, Pori, Finland;
,
Matti E. RantanenFinnish Cancer Registry, Helsinki, Finland;
,
Janne M. PitkäniemiFinnish Cancer Registry, Helsinki, Finland;
,
Nea K. MalilaFinnish Cancer Registry, Helsinki, Finland; ;School of Health Sciences, University of Tampere, Tampere, Finland
&
Peter J. BoströmDepartment of Urology, Turku University Hospital, University of Turku, Turku, Finland;
Pages 971-977 | Received 12 Aug 2016, Accepted 20 Jan 2017, Published online: 13 Feb 2017

Citations (11)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (2)

Heikki Seikkula, Antti Kaipia, Peter J. Boström, Nea Malila, Janne Pitkäniemi & Karri Seppä. (2022) Periodic trends in geographical variation of prostate cancer incidence and mortality in Finland between 1985 and 2019. Acta Oncologica 61:10, pages 1209-1215.
Read now
Kaire Innos, Aleksei Baburin, Andres Kotsar, Ivar-Endrik Eiche & Katrin Lang. (2017) Prostate cancer incidence, mortality and survival trends in Estonia, 1995–2014. Scandinavian Journal of Urology 51:6, pages 442-449.
Read now

Articles from other publishers (9)

Otto Ettala, Ivan Jambor, Ileana Montoya Perez, Marjo Seppänen, Antti Kaipia, Heikki Seikkula, Kari T Syvänen, Pekka Taimen, Janne Verho, Aida Steiner, Jani Saunavaara, Ekaterina Saukko, Eliisa Löyttyniemi, Daniel D Sjoberg, Andrew Vickers, Hannu Aronen & Peter Boström. (2022) Individualised non-contrast MRI-based risk estimation and shared decision-making in men with a suspicion of prostate cancer: protocol for multicentre randomised controlled trial (multi-IMPROD V.2.0). BMJ Open 12:4, pages e053118.
Crossref
Li‐Sha Luo, Jun‐Feng Jiang, Hang‐Hang Luan, Hao Zi, Cong Zhu, Bing‐Hui Li & Xian‐Tao Zeng. (2021) Spatial and temporal patterns of prostate cancer burden and their association with Socio‐Demographic Index in Asia, 1990–2019. The Prostate 82:2, pages 193-202.
Crossref
Ausvydas Patasius & Giedre Smailyte. (2021) All-Cause Mortality Risk in National Prostate Cancer Cohort: An Impact of Population-Based Prostate Cancer Screening. Journal of Clinical Medicine 10:11, pages 2459.
Crossref
Oskar Bergengren, Marcus Westerberg, Lars Holmberg, Pär Stattin, Anna Bill-Axelson & Hans Garmo. (2021) Variation in Prostate-Specific Antigen Testing Rates and Prostate Cancer Treatments and Outcomes in a National 20-Year Cohort. JAMA Network Open 4:5, pages e219444.
Crossref
Juan Chipollini & Grant R. Pollock. (2020) National trends in the management of low-risk prostate cancer: analyzing the impact of Medicaid expansion in the United States. International Urology and Nephrology 52:9, pages 1611-1615.
Crossref
Heikki Seikkula, Antti Kaipia, Elli Hirvonen, Matti Rantanen, Janne Pitkäniemi, Nea Malila & Peter J. Boström. (2020) Vasectomy and the risk of prostate cancer in a Finnish nationwide population-based cohort. Cancer Epidemiology 64, pages 101631.
Crossref
J. Smith-Palmer, C. Takizawa & W. Valentine. (2019) Literature review of the burden of prostate cancer in Germany, France, the United Kingdom and Canada. BMC Urology 19:1.
Crossref
Kathryn R. Tringale, John Pang & Quyen T. Nguyen. (2018) Image‐guided surgery in cancer: A strategy to reduce incidence of positive surgical margins. WIREs Systems Biology and Medicine 10:3.
Crossref
Anssi Auvinen, Antti Rannikko, Kimmo Taari, Paula Kujala, Tuomas Mirtti, Anu Kenttämies, Irina Rinta-Kiikka, Terho Lehtimäki, Niku Oksala, Kim Pettersson & Teuvo L. Tammela. (2017) A randomized trial of early detection of clinically significant prostate cancer (ProScreen): study design and rationale. European Journal of Epidemiology 32:6, pages 521-527.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.